Anti Obesity Medications in Patients With Heart Failure: Current Evidence and Practical Guidance Circulation: Heart Failure Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination What is the pipeline for future medications for obesity? International Journal of Obesity Tirzepatide (5mg 10mg 15mg 20mg 30mg) Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased